GAROFALO, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.206
AS - Asia 1.821
EU - Europa 1.138
AF - Africa 525
SA - Sud America 364
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 23
Totale 7.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.960
SG - Singapore 671
CN - Cina 320
IT - Italia 272
BR - Brasile 217
HK - Hong Kong 167
VN - Vietnam 151
DE - Germania 89
PL - Polonia 65
FI - Finlandia 57
NL - Olanda 46
GB - Regno Unito 42
RU - Federazione Russa 40
FR - Francia 35
AR - Argentina 33
BJ - Benin 33
IR - Iran 30
AT - Austria 29
ID - Indonesia 29
IE - Irlanda 28
KR - Corea 26
ES - Italia 25
SE - Svezia 24
UA - Ucraina 24
IL - Israele 21
IQ - Iraq 21
JO - Giordania 21
NZ - Nuova Zelanda 21
ET - Etiopia 20
GE - Georgia 20
ZA - Sudafrica 20
DZ - Algeria 19
EC - Ecuador 19
GN - Guinea 19
IN - India 19
LU - Lussemburgo 19
RO - Romania 19
CH - Svizzera 18
EG - Egitto 18
GR - Grecia 18
JM - Giamaica 18
NO - Norvegia 18
PS - Palestinian Territory 18
ME - Montenegro 17
ZM - Zambia 17
BA - Bosnia-Erzegovina 16
CV - Capo Verde 16
DK - Danimarca 16
EE - Estonia 16
LB - Libano 16
MA - Marocco 16
MK - Macedonia 16
MR - Mauritania 16
NP - Nepal 16
PT - Portogallo 16
UZ - Uzbekistan 16
YT - Mayotte 16
ZW - Zimbabwe 16
AO - Angola 15
BE - Belgio 15
JP - Giappone 15
MD - Moldavia 15
ML - Mali 15
MW - Malawi 15
PY - Paraguay 15
RS - Serbia 15
SI - Slovenia 15
SN - Senegal 15
TR - Turchia 15
AE - Emirati Arabi Uniti 14
AL - Albania 14
AZ - Azerbaigian 14
BB - Barbados 14
BO - Bolivia 14
CA - Canada 14
CL - Cile 14
CR - Costa Rica 14
CU - Cuba 14
CY - Cipro 14
GT - Guatemala 14
HN - Honduras 14
TW - Taiwan 14
UY - Uruguay 14
XK - ???statistics.table.value.countryCode.XK??? 14
AD - Andorra 13
AF - Afghanistan, Repubblica islamica di 13
BZ - Belize 13
CI - Costa d'Avorio 13
CO - Colombia 13
CZ - Repubblica Ceca 13
DJ - Gibuti 13
HT - Haiti 13
LC - Santa Lucia 13
LV - Lettonia 13
MX - Messico 13
NE - Niger 13
PA - Panama 13
PR - Porto Rico 13
TJ - Tagikistan 13
GA - Gabon 12
Totale 6.603
Salva come PNG Salva come JPEG
Città #
Fairfield 508
Ashburn 384
Singapore 319
Seattle 226
Woodbridge 211
Cambridge 177
Houston 171
Hong Kong 146
Wilmington 135
Chandler 116
Ann Arbor 89
Beijing 87
Padova 87
Santa Clara 85
Boardman 83
San Diego 55
Ho Chi Minh City 51
Medford 45
Princeton 45
Munich 41
Bytom 40
Chicago 39
Los Angeles 38
Hanoi 35
Cotonou 31
Hefei 31
Des Moines 28
Helsinki 27
Milan 27
Dong Ket 25
São Paulo 24
Dublin 23
Buffalo 19
Conakry 19
Amman 18
Nuremberg 17
Lappeenranta 16
Lusaka 16
Tbilisi 16
Vienna 16
Warsaw 16
Addis Ababa 15
Bamako 15
London 15
Podgorica 15
Seoul 15
Baku 14
Dakar 14
Havana 14
Jinan 14
Nouakchott 14
Tashkent 14
Athens 13
Castries 13
Dushanbe 13
Panama City 13
Praia 13
Stockholm 13
Abidjan 12
Andorra la Vella 12
Bridgetown 12
Harare 12
Lilongwe 12
Montevideo 12
Redondo Beach 12
Rio de Janeiro 12
Shenyang 12
Vientiane 12
Auckland 11
Libreville 11
Ljubljana 11
Luanda 11
Luxembourg 11
New York 11
Phnom Penh 11
Roxbury 11
Salt Lake City 11
Tallinn 11
Bishkek 10
Dar es Salaam 10
Djibouti 10
Kingston 10
Niamey 10
Padua 10
San José 10
Ulan Bator 10
Belize City 9
Guatemala City 9
Kampala 9
Limassol 9
Managua 9
Nairobi 9
Nanjing 9
San Francisco 9
Tripoli 9
Turku 9
Willemstad 9
Algiers 8
Cairo 8
Cape Town 8
Totale 4.252
Salva come PNG Salva come JPEG
Nome #
Physical PEGylation to Prevent Insulin Fibrillation 203
Dexamethasone loaded liposomes by thin‐film hydration and microfluidic procedures: Formulation challenges 168
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 162
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment 157
Thermosensitive "Smart" Surfaces for Biorecognition Based Cell Adhesion and Controlled Detachment 155
Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model 150
408. Oncolytic Vaccines in Combination with PD-L1 Blockade for the Treatment of Melanoma 146
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 144
From Immunosuppression to Immunomodulation – Turning Cold Tumours into Hot 143
Cancer vaccines: an update on recent achievements and prospects for cancer therapy 143
Heterologous and cross-species tropism of cancer-derived extracellular vesicles 140
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 140
Polymer coated oncolytic adenovirus to selectively target hepatocellular carcinoma cells 139
The evolution of adenoviral vectors through genetic and chemical surface modifications 137
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma 135
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 134
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer 134
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 130
220. Evaluation of the Efficacy of a New Oncolytic Vaccine Platform in Humanized Mice 130
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice. 130
Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies 129
PEG-polyaminoacid based micelles for controlled release of doxorubicin: Rational design, safety and efficacy study 125
The Anti-Proliferative Effect of L-Carnosine Correlates with a Decreased Expression of Hypoxia Inducible Factor 1 alpha in Human Colon Cancer Cells 124
661. Synergistic Anti-Tumor Efficacy of Immunogenic Adenovirus ONCOS-102 and Standard of Care Chemotherapy in Preclinical Mesothelioma Model 124
71. Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice 124
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 124
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation 122
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model 121
Screening of chemical linkers for development of pullulan bioconjugates for intravitreal ocular applications 120
PCSK9 promotes arterial medial calcification 120
Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model 119
Development of nanovehicles for co-delivery of colistin and ArnT inhibitors 115
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 115
622. Oncolytic Adenoviruses Loaded With Active Drugs as a Novel Drug Delivery System for Cancer Therapy 115
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review 114
Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform 112
Transplantation of autologous extracellular vesicles for cancer-specific targeting 110
Isoflavones in aglycone solution enhance ultraviolet B-induced DNA damage repair efficiency 109
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 109
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy 104
Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects 103
How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs 101
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity 100
L-Carnosine and Human Colon Cancer 100
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation 99
Erratum: The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells (PLoS ONE (2014) 9, 5 (e96755) DOI: 10.1371/journal.pone.0096755) 95
Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2 93
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 89
The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers 89
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines 89
MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy 87
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model 85
Oncolytic Adenovirus-Based Immunotherapy for Malignant Mesothelioma: Preclinical Advances and Future Perspectives 77
Application of array-CGH analysis in immune-virotherapy approach 74
Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review 73
Induction of an immune response by a nonreplicating adenoviruses-based formulation versus a commercial pseudo-SARS-CoV-2 vaccine 73
null 66
In vitro immune evaluation of adenoviral vector-based platform for infectious diseases 62
I Vaccini 62
L-Carnosine inhibits KRAS-mediated HCT116 proliferation, by affecting ROS production and Hypoxia inducible factor (HIF-1) expression 60
Unlocking the potential of microfluidic assisted formulation of exenatide-loaded solid lipid nanoparticles 55
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 53
Oncologia 53
Localized treatment of glioblastoma: a review of clinical strategies and advances in drug delivery systems 49
Doxorubicin liposomes cell penetration enhancement and its potential drawbacks for the tumor targeting efficiency 36
Development of an in vitro method to assess the immunogenicity of biologics in the prevention of infectious diseases 24
Dynamic 3D microfluidic platform for exploring combined targeted therapy, chemotherapy, and virotherapy delivery in ovarian cancer 10
Totale 7.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.499
article - articoli 22.587
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 725
Totale 46.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 16 69 82 82 70 86 43
2021/2022663 13 37 76 60 59 27 27 134 80 13 22 115
2022/2023335 73 1 4 23 70 46 1 38 46 3 15 15
2023/2024254 10 44 38 19 9 10 18 17 8 6 46 29
2024/20251.152 9 44 41 51 130 55 71 90 89 49 194 329
2025/20263.247 322 461 926 1.003 464 71 0 0 0 0 0 0
Totale 7.232